|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||
| Cash | ||||||||||||
| Prepaid expenses | ||||||||||||
| Total Current Assets | ||||||||||||
| Other assets | ||||||||||||
| Cash held in Trust Account | ||||||||||||
| Cash held in the Trust Account | ||||||||||||
| Available-for-sale debt securities held in Trust Account, at fair value (no allowance for credit losses, amortized cost $499,655,556) | ||||||||||||
| Total Assets | ||||||||||||
| Current Liabilities: | ||||||||||||
| Accrued expenses | ||||||||||||
| Sponsor loan – promissory notes | ||||||||||||
| Franchise tax payable | ||||||||||||
| Payables to related party | ||||||||||||
| Payable to related party | ||||||||||||
| Other current liability | ||||||||||||
| Total Current Liabilities | ||||||||||||
| Warrant liability | ||||||||||||
| Warrant liability | ||||||||||||
| FPS liability | ||||||||||||
| Total Liabilities | ||||||||||||
| Class A common stock subject to possible redemption, 7,549,677 and 10,251,420 shares issued and outstanding at redemption value of $10.52 and $10.06 per share as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||
| Stockholders’ Deficit: | ||||||||||||
| Class A common stock, $0.0001 par value; 240,000,000 shares authorized; 13,366,250 and 1,000,000 shares issued and outstanding (excluding 7,549,677 and 10,251,420 shares subject to possible redemption) as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||
| Class A Common Stock | ||||||||||||
| Class B Common Stock | ||||||||||||
| Total class A common stock, $0.0001 par value; 240,000,000 shares authorized; 13,366,250 and 1,000,000 shares issued and outstanding (excluding 7,549,677 and 10,251,420 shares subject to possible redemption) as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||
| Class B common stock, $0.0001 par value; 40,000,000 shares authorized; 133,750 and 12,500,000 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||
| Additional paid-in-capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| Accumulated other comprehensive loss | ||||||||||||
| Stockholders’ Deficit | ||||||||||||
| Class A Common Stock | ||||||||||||
| Class B Common Stock | ||||||||||||
| Total Stockholders’ Deficit | ||||||||||||
| Total Liabilities, Stockholders’ Deficit and Commitments and Contingencies |
Loading...
